Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Aug;37(8):879–881. doi: 10.1136/jcp.37.8.879

Consumption of fibrinolytic proteins in menstrual fluid from women with normal menstrual blood loss.

S A Cederholm-Williams, M C Rees, A C Turnbull
PMCID: PMC498886  PMID: 6540788

Abstract

Fibrinolytic proteins in menstrual fluid collected from women with normal menstrual blood loss (less than 80 ml) were found to be completely exhausted. High levels of tissue plasminogen activator, fibrin(ogen) degradation products, and plasmin-inhibitor complexes were present, but little fibrinolytically active plasmin remained. No difference was observed between days 1 and 2 of menstruation.

Full text

PDF
879

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRECHTSEN O. K. The fibrinolytic activity of the human endometrium. Acta Endocrinol (Copenh) 1956 Oct;23(2):207–218. doi: 10.1530/acta.0.0230207. [DOI] [PubMed] [Google Scholar]
  2. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  3. Bergsdorf N., Nilsson T., Wallén P. An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease. Thromb Haemost. 1983 Oct 31;50(3):740–744. [PubMed] [Google Scholar]
  4. Cederholm-Williams S. A. Control of fibrinolysis. Br J Hosp Med. 1983 Aug;30(2):107–110. [PubMed] [Google Scholar]
  5. Collen D. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost. 1980 Jun 18;43(2):77–89. [PubMed] [Google Scholar]
  6. HALLBERG L., NILSSON L. DETERMINATION OF MENSTRUAL BLOOD LOSS. Scand J Clin Lab Invest. 1964;16:244–248. [PubMed] [Google Scholar]
  7. Hahn L., Rybo G. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses. Acta Obstet Gynecol Scand. 1975;54(2):119–127. doi: 10.3109/00016347509156743. [DOI] [PubMed] [Google Scholar]
  8. Holmström B. Streptokinase assay on large agar diffusion plates. Acta Chem Scand. 1965;19(7):1549–1554. doi: 10.3891/acta.chem.scand.19-1549. [DOI] [PubMed] [Google Scholar]
  9. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  10. NILSSON I. M., BJOERKMAN S. E. EXPERIENCES WITH EPSILON-AMINOCAPROIC ACID (EPSILON-ACA) IN THE TREATMENT OF PROFUSE MENSTRUATION. Acta Med Scand. 1965 Apr;177:445–457. [PubMed] [Google Scholar]
  11. Smith O. W., VAN S Smith G. A FIBRINOLYTIC ENZYME IN MENSTRUATION AND LATE PREGNANCY TOXEMIA. Science. 1945 Sep 7;102(2645):253–254. doi: 10.1126/science.102.2645.253. [DOI] [PubMed] [Google Scholar]
  12. Teger-Nilsson A. C., Friberger P., Gyzander E. Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977 Sep;37(5):403–409. [PubMed] [Google Scholar]
  13. Wiman B., Collen D. On the kinetics of the reaction between human antiplasmin and plasmin. Eur J Biochem. 1978 Mar 15;84(2):573–578. doi: 10.1111/j.1432-1033.1978.tb12200.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES